Potent and Selective PTDSS1 Inhibitors Induce Collateral Lethality in Cancers with PTDSS2 Deletion.
Yohei YoshihamaHidenori NamikiTaiga KatoNaomi ShimazakiSachiko TakaishiKumiko Kadoshima-YamaokaHideo YukinagaNaoyuki MaedaTomoko ShibutaniKazunori FujimotoMakoto HirasawaHiroki GotoNaoya WadaShinji TsutsumiYasuhide HirotaTomoki IshikawaShoji YamamotoPublished in: Cancer research (2022)
This study identifies a specific dependency on PTDSS1 for phosphatidylserine synthesis following PTDSS2 deletion and introduces novel PTDSS1 inhibitors as a therapeutic option to induce collateral lethality in cancer with PTDSS2 loss.